Edaravone neuroprotection effected by suppressing the gene expression of the Fas signal pathway following transient focal ischemia in rats

Neurotoxicity Research

Volumn 12, Issue 3, 2007, Pages 155-162

  Xiao, Bo ^a   Bi, Fang Fang ^a,b   Hu, Yue Qiang ^a   Tian, Fa Fa ^a   Wu, Zhi Guo ^a   Mujlli, Hadi M ^a,c   Ding, Ling ^a   Zhou, Xin Fu ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b FLINDERS UNIVERSITY   (Australia)

^c Thamar Medical College   (China)

Author keywords

Cerebral ischemic reperfusion; Edaravone; Fas; Neuroprotective; Rat

Indexed keywords

CASPASE 8; DAXX PROTEIN; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; MESSENGER RNA; NORPHENAZONE; SODIUM CHLORIDE; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DRUG DERIVATIVE; NEUROPROTECTIVE AGENT; PHENAZONE; PHENYLMETHYLPYRAZOLONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG ACTIVITY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SIGNAL TRANSDUCTION; ANIMAL; DISEASE MODEL; DNA FRAGMENTATION; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; NEUROLOGIC EXAMINATION; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSIENT ISCHEMIC ATTACK;

RATTUS;

ANIMALS; ANTIPYRINE; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; GENE EXPRESSION REGULATION; IN SITU NICK-END LABELING; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC;

EID: 39749173050     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033912     Document Type: Article

References (30)

1. Amemiya S, T Kamiya, C Nito, T Inaba, K Kato, M Ueda, K Shimazaki and Y Katayama (2005) Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats. Eur. J. Pharmacol. 516(2), 125-130.
2. Boldin MP and TM Goncharov (1996) Involvement of MACH, a novel MORT1/ FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 85(6), 803-815.
3. Boldin MP, EE Varfolomeev, Z Pancer, IL Mett, JH Camonis and D Wallach (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270(14), 7795-7798.
4. Chan PH (1996) Role of oxidants in ischemic brain damage. Stroke 27(6), 1124-1129.
5. Chan PH (2001) Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21(1), 2-14.
6. Chan PH, JW Schmidley, RA Fishman and SM Longar (1984) Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals. Neurology 34(3), 315-320.
7. Chang HY, N Nishitoh, X Yang, H Ichijo and D Baltimore (1998) Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281(5384), 1860-1863.
8. Charriaut-Marlangue C, I Margaill, M Plotkine and Y Ben-Ari (1996) Apoptosis and necrosis after reversible focal ischemia: An in situ DNA fragmentation analysis. J. Cereb. Blood Flow Metab. 16(2), 186-195.
9. Chinnaiyan AM, K O'Rourke, M Tewari and VM Dixit (1995) FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis. Cell 81(4), 505-512.
10. Fujimura M, Y Morita-Fujimura, N Noshita, T Sugawara, M Kawase and PH Chan (2000) The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. J. Neurosci. 20(8), 2817-2824.
11. Gilgun-Sherki Y, Z Rosenbaum, E Melamed and D Offen (2002) Antioxidant therapy in acute central nervous system injury: Current state. Pharmacol. Rev. 54(2), 271-284.
12. 2+ channel blocker, in a focal ischemic model in the rat. Brain Res. 969(1-2), 168-174.
13. Kawai H, H Nakai, M Suga, S Yuki, T Watanabe and KI Saito (1997) Effects of a novel free radical scavenger, MCI-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J. Pharmacol. Exp. Ther. 281(2), 921-927.
14. Kim GW, T Sugawara and PH Chan (2000) Involvement of oxidative stress and caspase-3 in cortical infarction after photothrombotic ischemia in mice. J. Cereb. Blood Flow Metab. 20(12), 1690-1701.
15. Li Y, M Chopp, C Powers and N Jiang (1997) Apoptosis and protein expression after focal cerebral ischemia in rat. Brain Res. 765(2), 301-312.
16. Li Y, C Powers, N Jiang and M Chopp (1998) Intact, injured, necrotic and apoptotic cells after focal cerebral ischemia in the rat. J. Neurol. Sci. 156(2), 119-132.
17. MacManus JP and MD Linnik (1997) Gene expression induced by cerebral ischemia: An apoptotic perspective. J. Cereb. Blood Flow Metab. 17(8), 815-832.
18. Morimoto T, MY Globus, R Busto, E Martinez and MD Ginsberg (1996) Simultaneous measurement of salicylate hydroxylation and glutamate release in the penumbral cortex following transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 16(1), 92-99.
19. Muzio M, AM Chinnaiyan, FC Kischkel, K O'Rourke, A Shevchenko, J Ni, C Scaffidi, JD Bretz, M Zhang, R Gentz, M, Mann, PH Drammer, ME Peter and VM Dixit (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85(6), 817-827.
20. Namura S, I Nagata, S Takami, H Masayasu and H Kikuchi (2001) Ebselen reduces cytochrome c release from mitochondria and subsequent DNA fragmentation after transient focal cerebral ischemia in Mice. Stroke 32(8), 1906-1911.
21. Nito C, T Kamiya, M Ueda, T Arii and Y Katayama (2004) Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats. Brain Res. 1008(2), 179-185.
22. Shichinohe H, S Kuroda, H Yasuda, T Ishikawa, M Iwai, M Horiuchi and Y Iwasaki (2004) Neuroprotective effects of the free radical scavenger edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res. 1029(2), 200-206.
23. Solenski NJ, A-L Kwan, H Yanamoto, JP Bennett, NF Kassell and KS Lee (1997) Differential hydroxylation of salicylate in core and penumbra regions during focal reversible cerebral ischemia. Stroke 28(12), 2545-2552.
24. Swanson RA, MT Morton, G Tsao-Wu, RA Savalos, C Davidson and FR Sharp (1990) A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10(2), 290-293.
25. Watanabe T, YS, M Egawa and H Nishi (1994) Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions. J. Pharmacol. Exp. Ther. 268(3), 1597-1604.
26. Wu T-W, L-H Zeng, J Wu and KP Fung (2000) MCI-186: Further histochemical and biochemical evidence of neuroprotection. Life Sci. 67(19), 2387-2392
27. Xu X-H, S-M Zhang, WM Yan, XR Li, HY Zhang and XX Zheng (2006) Development of cerebral infarction, apoptotic cell death and expression of X-chromosome-linked inhibitor of apoptosis protein following focal cerebral ischemia in rats. Life Sci. 78(7), 704-712.
28. Yang X, R Khosravi-Far, HY Chang and D Baltimore (1997) Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89(7), 1067-1076.
29. Yasuoka N, NW, A Ishida and G Takada (2004) Neuroprotection of edaravone on hypoxic-ischemic brain injury in neonatal rats. Brain Res. Dev. Brain Res. 151(1-2), 129-139.
30. Zhang L, J Chen, Y Li, ZG Zhang and M Chopp (2000) Quantitative measurement of motor and somatosensory impairments after mild (30 min) and severe (2 h) transient middel cerebral artery occlusion in rats. J. Neurol. Sci. 174, 141-146.